Burgess Mark T, Porter Tyrone M
Department of Mechanical Engineering and Center for Nanoscience and Nanobiotechnology, Boston University, Boston, Massachusetts, USA.
Department of Mechanical Engineering and Center for Nanoscience and Nanobiotechnology, Boston University, Boston, Massachusetts, USA; Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA.
Ultrasound Med Biol. 2015 Aug;41(8):2191-201. doi: 10.1016/j.ultrasmedbio.2015.04.002. Epub 2015 May 13.
Localized, targeted delivery of small interfering ribonucleic acid (siRNA) has been the foremost hurdle in the use of siRNA for the treatment of various diseases. Major advances have been achieved in the synthesis of siRNA, which have led to greater target messenger RNA (mRNA) silencing and stability under physiologic conditions. Although numerous delivery strategies have shown promise, there are still limited options for targeted delivery and release of siRNA administered systemically. In this in vitro study, phase-shift nano-emulsions (PSNE) were explored as cavitation nuclei to facilitate free siRNA delivery to cancer cells via sonoporation. A cell suspension containing varying amounts of PSNE and siRNA was exposed to 5-MHz pulsed ultrasound at fixed settings (6.2-MPa peak negative pressure, 5-cycle pulses, 250-Hz pulse repetition frequency (PRF) and total exposure duration of 100 s). Inertial cavitation emissions were detected throughout the exposure using a passive cavitation detector. Successful siRNA delivery was achieved (i.e., >50% cell uptake) with high (>80%) viability. The percentage of cells with siRNA uptake was correlated with the amount of inertial cavitation activity generated from vaporized PSNE. The siRNA remained functional after delivery, significantly reducing expression of green fluorescent protein in a stably transfected cell line. These results indicate that vaporized PSNE can facilitate siRNA entry into the cytosol of a majority of sonicated cells and may provide a non-endosomal route for siRNA delivery.
小干扰核糖核酸(siRNA)的局部靶向递送一直是将siRNA用于治疗各种疾病的首要障碍。siRNA合成方面已取得重大进展,这使得在生理条件下能实现更强的靶信使核糖核酸(mRNA)沉默和稳定性。尽管众多递送策略已展现出前景,但全身性给药的siRNA靶向递送和释放的选择仍然有限。在这项体外研究中,探索了相移纳米乳液(PSNE)作为空化核,以通过声穿孔促进游离siRNA向癌细胞的递送。将含有不同量PSNE和siRNA的细胞悬液在固定设置(6.2兆帕峰值负压、5个周期脉冲、250赫兹脉冲重复频率(PRF)和100秒总暴露持续时间)下暴露于5兆赫脉冲超声。在整个暴露过程中使用被动空化探测器检测惯性空化发射。以高存活率(>80%)成功实现了siRNA递送(即>50%细胞摄取)。摄取siRNA的细胞百分比与汽化PSNE产生的惯性空化活性量相关。递送后siRNA仍保持功能,显著降低了稳定转染细胞系中绿色荧光蛋白的表达。这些结果表明,汽化的PSNE可促进siRNA进入大多数超声处理细胞的细胞质,并可能为siRNA递送提供一条非内体途径。